These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12361202)

  • 1. Effect of hemodialysis on plasma levels of vascular endothelial markers.
    Naumnik B; Borawski J; Pawlak K; Myśliwiec M
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):245-50. PubMed ID: 12361202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy.
    Borawski J; Naumnik B; Mysliwiec M
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):359-67. PubMed ID: 12516686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
    Naumnik B; Pawlak K; Mys'liwiec M
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Method of dialysis therapy and selected markers of oxidative stress and endothelial injury in patients with chronic renal failure].
    Pawlak K; Pawlak D; Myśliwiec M
    Pol Arch Med Wewn; 2005 Jan; 113(1):21-6. PubMed ID: 16130597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
    Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
    Jacobson SH; Egberg N; Hylander B; Lundahl J
    Am J Nephrol; 2002; 22(1):42-7. PubMed ID: 11919402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
    Naumnik B; Borawski J; Myśliwiec M
    Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of the three endothelial-specific proteins von Willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome.
    Bajaj MS; Tricomi SM
    Intensive Care Med; 1999 Nov; 25(11):1259-66. PubMed ID: 10654210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy.
    Tomura S; Nakamura Y; Deguchi F; Chida Y; Ohno Y; Kodama S; Hayashi T; Suzuki K; Marumo F
    Thromb Res; 1990 May; 58(4):413-9. PubMed ID: 2162087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
    Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
    Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
    Pawlak K; Naumnik B; Brzósko S; Pawlak D; Myśliwiec M
    Am J Nephrol; 2004; 24(1):154-61. PubMed ID: 14726627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor coagulation pathway and blood cells activation state in renal insufficiency.
    Mercier E; Branger B; Vecina F; Al-Sabadani B; Berlan J; Dauzat M; Fourcade J; Gris JC
    Hematol J; 2001; 2(1):18-25. PubMed ID: 11920229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients.
    Pawlak K; Borawski J; Naumnik B; Mysliwiec M
    Thromb Res; 2003 Mar; 109(5-6):247-51. PubMed ID: 12818246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
    Hagag AA; Abdel-Lateef AE; Aly R
    J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function, proteinuria and ACE-inhibitor therapy as determinants of plasma levels of endothelial markers.
    Naumnik B; Borawski J; Pawlak K; Myśliwiec M
    Nephrol Dial Transplant; 2002 Mar; 17(3):526-8. PubMed ID: 11865114
    [No Abstract]   [Full Text] [Related]  

  • 17. Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
    Czupryniak A; Kałuzyńska A; Nowicki M; Wiecek B; Bald E; Owczarek D
    Kidney Blood Press Res; 2005; 28(1):27-31. PubMed ID: 15452382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of unfractionated and low-molecular-weight heparin on OPG, sRANKL, and von Willebrand factor concentrations during hemodialysis.
    Klejna K; Naumnik B; Koc-Żórawska E; Myśliwiec M
    Clin Appl Thromb Hemost; 2014 May; 20(4):433-41. PubMed ID: 23104956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial injury markers with high-dose intravenous iron therapy in renal failure.
    Borawski J; Gozdzikiewicz J; Abramowicz P; Naumnik B; Mysliwiec M
    Clin Appl Thromb Hemost; 2004 Oct; 10(4):403-6. PubMed ID: 15497030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
    Leurs PB; Stolk RP; Hamulyak K; Van Oerle R; Grobbee DE; Wolffenbuttel BH
    Diabetes Care; 2002 Aug; 25(8):1340-5. PubMed ID: 12145232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.